| Date Filed | Type | Description |
| 10/05/2023 |
4
| Bozic Carmen (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 5,651 shares
@ $345.28, valued at
$2M
|
|
| 02/22/2023 |
4
| Bozic Carmen (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,750 shares
@ $292.85, valued at
$1.1M
|
|
| 02/14/2023 |
4
| Bozic Carmen (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 2,707 shares
@ $294.33, valued at
$796.8k
Paid exercise price by delivering 4,992 shares
@ $298.26, valued at
$1.5M
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Bozic Carmen (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 2,437 shares
@ $237.74, valued at
$579.4k
|
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Bozic Carmen (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 311 shares
@ $217.57, valued at
$67.7k
|
|
| 02/12/2021 |
4
| Bozic Carmen (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 2,367 shares
@ $214.16, valued at
$506.9k
|
|
| 02/05/2021 |
4
| Bozic Carmen (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 10,324 shares
@ $0
Granted 11,627 shares
@ $0 |
|
| 06/02/2020 |
4
| Bozic Carmen (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 311 shares
@ $282.74, valued at
$87.9k
|
|
| 02/26/2020 |
4
| Bozic Carmen (EVP, GMDA) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 216 shares
@ $239.23, valued at
$51.7k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |